Tirzepatide being a dual GLP-1 and GIP agonist, it is actually advised that the GIP ingredient of twin agonism could be chargeable for the extra reward, presented the likely benefit of GIP receptor agonism on peripheral insulin sensitization. For that reason, tirzepatide was more practical than dulaglutide in lessening fasting dietary TAG [six,sev